DRUG ALBUM PKDHS 2021

RIFAMPICIN 150MG + ISONIAZID 75MG
TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C
SPECIAL COUNSELING POINT
Compatible

- Advise patient to report symptoms
of hepatotoxicity and cutaneous
adverse reaction.

- Ask patient to take pyridoxine in
the regimen to avoid vitamin B6
deficiency.

237

RIFAMPICIN 300 MG CAPSULE

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C
SPECIAL COUNSELING POINT
Compatible

- Advise patient to report symptoms
of hepatotoxicity and cutaneous
adverse reaction.

- Counsel that drug may cause
discolouration of teeth, urine,
sweat, sputum and tears.

238

RISPERIDONE 1 MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C
SPECIAL COUNSELING POINT
Limited Human Data- Potential toxicity

- Counsel patient to avoid activities
requiring mental alertness or
coordination.

- Tell patient to report symptoms of
EPS, tardive dyskinesia or

neuroleptic malignant syndrome.

239

RISPERIDONE 2 MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C
SPECIAL COUNSELING POINT
Limited Human Data- Potential toxicity

- Counsel patient to avoid activities
requiring mental alertness or
coordination.

- Tell patient to report symptoms of
EPS, tardive dyskinesia or

neuroleptic malignant syndrome.

240

SALBUTAMOL 0.5 % INHALATION
SOLUTION

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C
SPECIAL COUNSELING POINT
No human data- probably compatible

- Prolong use of neb salbutamol can
lead to hypokalemia.

- Side effect may include
palpitations, chest pain, tremors

and nervousness.

241

SALBUTAMOL 100 MCG/DOSE
INHALATION

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C
SPECIAL COUNSELING POINT
No human data- probably compatible

Must be carried together everywhere in
case of emergency.

242

SALBUTAMOL 2 MG/5 ML SYRUP

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C
SPECIAL COUNSELING POINT
No human data- probably compatible

- Used for patient more than 2 years
old.

- Side effect may include
palpitations, chest pain, tremors

and nervousness.

243

SALICYLIC ACID 2 - 10% OINTMENT

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C- but not recommended in psoriasis
treatment
SPECIAL COUNSELING POINT
Systemic absorption of topical
administration is minimal – can be use

in breastfeed but avoid chest area.
-Apply carefully onto warts.

- Advise to protect surrounding skin
with soft paraffin.

244

SALMETEROL 50 MCG AND
FLUTICASONE PROPIONATE 250 MCG

INHALATION

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C
SPECIAL COUNSELING POINT
Limited data available

- Advise patient not to be used to
relieve acute symptoms and extra
doses should not be used for that
purpose.

- Advise to gargle mouth after using
to reduce risk of oral candidiasis.

245

SELENIUM SULPHIDE 2.5% SHAMPOO

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C

SPECIAL COUNSELING POINT Use with caution- not known if present
in breast milk

- Advise patient that this drug can
cause burning and contact
dermatitis.

- Apply daily for 1 week to affected
area for 10-15 minutes followed by
shower and rinse off. Then apply 2-3
times per week.

246

SERTRALINE HCL
50MG TABLET

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C

SPECIAL COUNSELING POINT Safe, as the amount ingested by the
infant is small & usually not detected

Avoid driving a car or operate
machinery after taking this medication

247

Silver Sulfadiazine
1% Cream

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C , X (near term)

SPECIAL COUNSELING POINT Not known if distributed into breast
milk; use with caution

Contraindicated for patient with G6PD
deficiency, sulfa allergy, premature
infants or infants age < 2 months old

248

Simvastatin
20 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY
LACTATION X

SPECIAL COUNSELING POINT No relevant published information. Due
to concern with disruption of infant

lipid metabolism, consensus stated not
to be used during breastfeed

May cause dizziness, myopathy or
rhabdomyolysis. Inform the doctor if

symptoms persist

249

Simvastatin
40 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY
LACTATION X

SPECIAL COUNSELING POINT No relevant published information. Due
to concern with disruption of infant

lipid metabolism, consensus stated not
to be used during breastfeed

May cause dizziness, myopathy or
rhabdomyolysis. Inform the doctor if

symptoms persist

250

Sodium Bicarbonate 8.4% (1 mmol/ml)
Injection

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
SPECIAL COUNSELING POINT No published data
Avoid use in patient with renal and
hepatic impairment or other conditions
associated with sodium retention

251

Sodium Bicarbonate and Magnesium
Carbonate Compound Mixture

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C
SPECIAL COUNSELING POINT
No published data

Shake well before use and monitor any
signs of hypersensitivity reactions

252

Sodium Bicarbonate, Citric Acid, Sodium
Citrate and Tartaric Acid – 4g/sachet

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
SPECIAL COUNSELING POINT No published data
Must be dissolved in cold water before
taking it. Ensure adequate fluid intake

253

Sodium Chloride 0.18% with Dextrose
4.23% Injection

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
SPECIAL COUNSELING POINT No published data
Monitor serum potassium and other

electrolytes levels

254

Sodium Chloride
0.45% Injection

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
SPECIAL COUNSELING POINT No published data
Monitor fluid balance, electrolyte
concentrations and acid-base balance

255

Sodium Chloride 0.45% with Dextrose
5% Injection

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
SPECIAL COUNSELING POINT No published data
Monitor serum potassium and other

electrolytes levels

256

Sodium Chloride
0.9% Eye Drops

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
SPECIAL COUNSELING POINT No published data
Discard after one month of opening the
bottle and it should not be shared with
other people with the same symptoms

257

Sodium Chloride
0.9% Injection

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
SPECIAL COUNSELING POINT No published data
Monitor fluid balance, electrolyte
concentrations and acid-base balance

258

Sodium Valproate
200 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY
LACTATION D, X (if used for migraine prophylaxis)

SPECIAL COUNSELING POINT Breastfed infants are at risk for valproic
acid-induced hepatotoxicity; monitor

any signs of liver damage
(jaundice/unusual bleeding or bruising)

during maternal therapy
Swallow whole (do not chew/crush).
Seek medical advice during first signs of

pancreatitis (eg: abdominal pain,
nausea, vomit and anorexia), blood &

liver toxicity

259

Spironolactone
25 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C

SPECIAL COUNSELING POINT Acceptable to be used during
breastfeeding

May cause frequent urination and
dehydration; drink more water. May
cause dizziness/drowsiness; do not
drive or operate machinery if affected.

260

Streptomycin Sulphate
1 g Injection

CATEGORY DESCRIPTION
PREGNANCY
LACTATION D

SPECIAL COUNSELING POINT Poorly excreted into breastmilk but
monitor possible effects such as

diarrhea/thrush/diaper rash/bloody
stool

Monitor any hypersensitivity reactions,
renal and auditory functions

261

Sulphamethoxazole 400 mg &
Trimethoprim 80 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY
LACTATION D

SPECIAL COUNSELING POINT No published data but because of
potential risk of bilirubin displacement

& kernicterus, avoid breastfeeding
during therapy

Monitor any signs of hypersensitivity
reactions. Must be avoided in hepatic

impairment patient

262

Sulpiride
200 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
SPECIAL COUNSELING POINT No relevant published information
May cause sedation; do not drive or

operate machinery. Avoid its
consumption with alcohol

263

Telmisartan
40 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY D
LACTATION
SPECIAL COUNSELING POINT No relevant published information
May cause dizziness or drowsiness.
Monitor any hypersensitivity symptoms

264

Telmisartan
80 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY D
LACTATION
SPECIAL COUNSELING POINT No relevant published information
May cause dizziness or drowsiness.
Monitor any hypersensitivity symptoms

265

Tenofovir Disoproxil Fumarate 300 mg
& Emtricitabine 200 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY
LACTATION B

SPECIAL COUNSELING POINT Present in human breast milk and HIV-
infected mothers are not recommended

to breastfeed their infants
Must be taken consistently everyday
either with or without food. Monitor

any signs of hypersensitivity

266

Tetanus Toxoid
Injection

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
SPECIAL COUNSELING POINT No relevant published information
Monitor any signs of hypersensitivity
reactions. Report any adverse effects

developed after the immunization

267

Theophylline
250 mg Long Acting Tablet

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C

SPECIAL COUNSELING POINT Its use is acceptable during
breastfeeding. However, monitor the
side effects especially in neonates and

premature infants

Swallow whole after meal. Monitor any
signs of toxicity/hypersensitivity.

268

Thymol
Compound Gargle

CATEGORY DESCRIPTION
PREGNANCY No data available
LACTATION No published data
SPECIAL COUNSELING POINT Dilute 1 part of the thymol solution into
3 parts of water before gargle. Not for

swallow

269

Ticlopidine HCl
250 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY
LACTATION B
SPECIAL COUNSELING POINT
No relevant published information

Inform all the healthcare providers that
you are taking this medication before
undergoing any surgical procedure or

plan to take any supplements

270

Tiotropium 2.5mcg/puff solution for
inhalation

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C

SPECIAL COUNSELING POINT No published data, but the risk to the
breastfed infant is small

Protect the capsule form excessive heat
and moisture. Do not store it in the
inhaler device.

271

Tramadol HCl
50 mg Capsule

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C

SPECIAL COUNSELING POINT A study showed no adverse effects to
the nursing infants. However, it is

recommended to monitor for increased
sleepiness, breastfeeding/breathing
difficulties or limpness if tramadol is
taken

May cause drowsiness, avoid driving or
operate machinery

272

Tranexamic Acid
250 mg Capsule

CATEGORY DESCRIPTION
PREGNANCY B
LACTATION
Safe, amount in breastmilk is low & no
SPECIAL COUNSELING POINT adverse effect to the infant

May cause drowsiness, avoid driving or
operate machinery. Avoid taking it with

combined OCP

273

Trifluoperazine HCI
5 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
SPECIAL COUNSELING POINT Limited data available
Should be taken with food to reduce GI

upset & must not be taken within 2
hours of antacids

274

Trimetazidine
20 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY No data
LACTATION
SPECIAL COUNSELING POINT No data available
Should be taken with food. May cause
dizziness and drowsiness, avoid driving

or operate machinery

275

Triprolidine HCl 2.5 mg and
Pseudoephedrine HCl 60 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C

SPECIAL COUNSELING POINT Small dose is safe but may cause a
decrease in milk supply. Non-sedative

antihistamine is more preferred
May cause drowsiness, avoid driving or

operate machinery

276

Tuberculine PPD
Injection

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
SPECIAL COUNSELING POINT Safe
Do not rub or massage the injection
site. Measurement will be taken within

48-72hr after injection

277

Valsartan 160 mg and
Hydrochlorothiazide 25 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY D
LACTATION
SPECIAL COUNSELING POINT No relevant published information
Will cause frequent urination.

Monitor any signs of hypersensitivity
reactions

278

Valsartan
160 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY
LACTATION D
SPECIAL COUNSELING POINT
No relevant published information

May cause dizziness or weariness, avoid
driving or operate machinery if
affected. Monitor any signs of
hypersensitivity reactions

279

Valsartan 80 mg and
Hydrochlorothiazide 12.5 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY D
LACTATION
SPECIAL COUNSELING POINT No relevant published information
Will cause frequent urination.

Monitor any signs of hypersensitivity
reactions

280

Valsartan
80 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY
LACTATION D
SPECIAL COUNSELING POINT
No relevant published information

May cause dizziness or weariness, avoid
driving or operate machinery if
affected. Monitor any signs of
hypersensitivity reactions

281

Varenicline Tartrate
0.5 mg and 1 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C

SPECIAL COUNSELING POINT No relevant published information. But
if the mother chooses to take it during

breastfeed, monitor her infant for
seizure & excessive vomiting

May impair ability to drive or operate
machineries. Avoid taking it with

excessive alcohol. Notify the healthcare
professionals In case of serious
neuropsychiatric adverse effects
develop

282

Varenicline Tartrate
1 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY
LACTATION C

SPECIAL COUNSELING POINT No relevant published information. But
if the mother chooses to take it during

breastfeed, monitor her infant for
seizure & excessive vomiting

May impair ability to drive or operate
machineries. Avoid taking it with

excessive alcohol. Notify the healthcare
professionals In case of serious
neuropsychiatric adverse effects
develop

283

Verapamil HCl
40 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY C
LACTATION
SPECIAL COUNSELING POINT Safe
Take after meal. Avoid taking it with
grapefruit juice, alcohol and St. John’s

wort supplement

284

Vildagliptin
50 mg Tablet

CATEGORY DESCRIPTION
PREGNANCY No data
LACTATION
SPECIAL COUNSELING POINT No published data
May be taken with or without meal.
Monitor any signs of hypersensitivity

reactions

285

Vitamin B Complex
Tablet

CATEGORY DESCRIPTION
PREGNANCY A
LACTATION
SPECIAL COUNSELING POINT No published data
May be taken with or without meal.
Monitor any signs of hypersensitivity

reactions. May slightly increase
appetite

286